Navigating Melanoma During the Holidays
The holiday season is often portrayed as a time of joy, love, and celebration. However, for melanoma cancer patients, it…
12/19/2023
Navigating Melanoma During the Holidays
The holiday season is often portrayed as a time of joy, love, and celebration. However, for melanoma cancer patients, it…
|
12/18/2023
The Clinical Trial Experience: A Patient’s Perspective
In 2010, Mary Elizabeth Williams was diagnosed with metastatic melanoma. The following year, she was offered the opportunity to participate…
|
12/05/2023
Celebrate Survivorship – Give Towards Melanoma Research
Melanoma knows no boundaries. It’s a disease that affects people of all ages, races, and backgrounds. And it’s a devastating…
|
11/14/2023
Melanoma Cancer and Financial Toxicity
While being diagnosed with cancer alone can put a person under tremendous amounts of mental and emotional stress, the additional…
|
10/31/2023
National Family Caregiver Month
National Caregiver Month is observed every November to honor and appreciate the selfless individuals who dedicate their lives to caring…
|
10/23/2023
Immunocore Presents Three-Year Overall Survival Data from the KIMMTRAK Phase 3 Trial
Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial Published: Oct 21, 2023 Data published in New…
|
|
10/15/2023
Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma
October 13, 2023 17:30 ET| Source: Bristol Myers Squibb In the Phase 3 CheckMate -76K trial, Opdivo demonstrated a statistically significant…
|
|
10/13/2023
That Good Night: Life and Medicine in the Eleventh Hour
A growing discipline, palliative care medicine remains underutilized. Studies suggest that patients and providers commonly confuse palliative care with end-of-life…
|
09/17/2023
Notes from the Lab: Novel targets for immune checkpoint inhibitors
By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory Survival rates of patients with melanoma have drastically improved in the…
|
09/12/2023
Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center
Last year, over 197,000 Americans were diagnosed with melanoma—and we know they won’t go through that experience alone because there…
|
Recent Posts
Feb. 19, 2026
Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN®
Feb. 05, 2026
Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma
Jan. 23, 2026
Moderna, Merck’s Skin Cancer Vaccine Shows Sustained Benefit in Five-Year Follow-Up
Jan. 21, 2026
Reflecting on Melanoma Treatment in 2025 and Looking to the Future in 2026
Jan. 13, 2026